United States · FDA National Drug Code directory
Nalbuphine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0409-1464_cbcbf107-67c0-4a8a-a25d-5a05c43a0bfd
- Product NDC
- 0409-1464
- Form
- INJECTION, SOLUTION
- Composition / generic term
- NALBUPHINE HYDROCHLORIDE
- Labeler
- Hospira, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20050719
- Source listing expiry
- 20261231
Source-listed ingredients
- NALBUPHINE HYDROCHLORIDE — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 CARTON in 1 CASE (0409-1464-01) / 1 VIAL, MULTI-DOSE in 1 CARTON (0409-1464-61) / 10 mL in 1 VIAL, MULTI-DOSE · 0409-1464-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →